Sign In

7.9 : Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.

Unlike nondepolarizing blockers, succinylcholine, a depolarizing blocker, has more severe adverse effects, including hyperkalemia, arrhythmia, postoperative muscle pain, increased intraocular pressure, and regurgitation of gastric content due to increased gastric pressure.

Adverse effects of directly acting agents like botulinum toxin and dantrolene include general muscle weakness and hepatotoxicity. Additionally, botulinum toxin can cause respiratory tract infections and loss of bladder control.

Lastly, centrally acting muscle relaxants, which affect the central nervous system or CNS, induce various symptoms of CNS depression. For example, tizanidine causes drowsiness, hypotension, dizziness, dry mouth, and hepatotoxicity, whereas diazepam causes anxiety, tremors, insomnia, and hallucinations. Avoiding high drug doses from being given to at-risk patients such as epileptic patients or pregnant women may help reduce the severity of the side effects.

Tags
Skeletal Muscle RelaxantsAdverse EffectsMuscle ParalysisNondepolarizing Neuromuscular BlockersHypotensionBaclofenSpastic ConditionsSuccinylcholineHyperkalemiaArrhythmiaPostoperative Muscle PainBotulinum ToxinDantroleneCNS DepressionTizanidineDiazepamHepatotoxicity

From Chapter 7:

article

Now Playing

7.9 : Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants

251 Views

article

7.1 : Neuromuscular Junction And Blockade

Skeletal Muscle Relaxants

1.9K Views

article

7.2 : Classification of Skeletal Muscle Relaxants

Skeletal Muscle Relaxants

2.1K Views

article

7.3 : Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Skeletal Muscle Relaxants

972 Views

article

7.4 : Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Skeletal Muscle Relaxants

276 Views

article

7.5 : Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

Skeletal Muscle Relaxants

356 Views

article

7.6 : Depolarizing Blockers: Mechanism of Action

Skeletal Muscle Relaxants

839 Views

article

7.7 : Depolarizing Blockers: Pharmocokinetics

Skeletal Muscle Relaxants

228 Views

article

7.8 : Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Skeletal Muscle Relaxants

433 Views

article

7.10 : Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants

380 Views

article

7.11 : Spasmolytic Agents: Chemical Classification

Skeletal Muscle Relaxants

765 Views

article

7.12 : Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal Muscle Relaxants

2.7K Views

article

7.13 : Centrally Acting Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants

395 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved